Skip to main content

Table 2 aMutual predicatbility score of breast cancer drug candiates predicted by MFM

From: A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer

FDA Drug

aMP score

P-value

FDR

Clotrimazole

0.7

5.00E-06

4.88E-05

Triprolidine

0.69

2.00E-05

1.64E-04

Thioridazine

0.69

2.00E-05

1.64E-04

Mefloquine

0.69

3.00E-05

2.28E-04

Fluphenazine

0.66

1.11E-02

2.13E-02